Conservatively managed non-functioning pituitary macroadenomas—cohort study from the UK Non-functioning Pituitary Adenoma Consortium
Open Access
- 30 April 2025
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 192 (5) , 680-690
Abstract
Objective: Surveillance is often adopted for asymptomatic non-functioning pituitary macroadenomas (macroNFPAs). Due to low-quality evidence, uncertainty remains on optimal frequency of imaging/biochemical monitoring and indications for surgery. We assessed the natural history and outcomes of patients with macroNFPA who had monitoring as initial management choice from the UK NFPA Consortium. Design: This was a multicentre, retrospective, cohort study involving 21 UK endocrine departments. Methods: Clinical, imaging, and hormonal data of 949 patients followed up between January, 1, 2005 and March, 1, 2022 were analysed. Results: Incidence rate for tumour enlargement was 9.8 per 100 patient-years (95% CI, 8.8-10.8), with cumulative probabilities 1.6%, 8.1%, 18.4%, 29.2%, and 43.6% at 6-month, 1-year, 2-year, 3-year, and 5-year follow-up, respectively; rates were higher in tumours abutting/displacing optic chiasm than those not in contact with it. Amongst macroNFPAs not in contact with optic chiasm showing enlargement within 6 months, none impacted visual fields. In tumours with enlargement and continued monitoring (median 2.6 years), further growth occurred in 60.5% (33.8% probability at 2 years), stability in 35.5%, and shrinkage in 4.0%. Rates of new pituitary hormone deficits were 4.0%-4.9%, mainly driven by tumour enlargement. After transsphenoidal surgery, rates of hypopituitarism reversal were 12%-17% and those of additional anterior pituitary hormone deficits were 12%-15% (permanent vasopressin deficiency 3.5%). Conclusions: Our data provide evidence for monitoring protocols. MacroNFPAs not in contact with optic chiasm require less frequent imaging, and first follow-up scan can be delayed to 1 year. After first enlargement, variable tumour behaviour can occur. New hypopituitarism in stable tumours is rare, challenging necessity of regular pituitary function assessment.Keywords
This publication has 25 references indexed in Scilit:
- Natural History of Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-AnalysisHormone and Metabolic Research, 2023
- Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortiumEuropean Journal of Endocrinology, 2023
- Pituitary Incidentalomas in the United States: A National Database EstimateWorld Neurosurgery, 2022
- First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary TumorsExperimental and Clinical Endocrinology & Diabetes, 2021
- Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomasPituitary, 2018
- Prevalence, Clinical Features, and Natural History of Incidental Clinically Non-Functioning Pituitary AdenomasHormone and Metabolic Research, 2017
- Sellar Masses: An Epidemiological StudyCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2015
- Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomasClinical Endocrinology, 2015
- Management of clinically non-functioning pituitary adenomaAnnales d'Endocrinologie, 2015
- Radiologic follow-up of non-functioning pituitary adenomas: rationale and cost effectivenessJournal of Neuro-Oncology, 2009